Patient Medication Information: uses, side effects, how to take - Flumazenil Injection, USP (Mylan Pharmaceuticals)
ABOUT THIS MEDICATION
What the medication is used for:
Reversing drowsiness, sedation, and other effects caused by a medicine within a group of medicines called benzodiazepines. It may be used to wake you up after anesthesia or if you have been in intensive care.
What it does:
Flumazenil Injection, USP contains the active ingredient flumazenil. Flumazenil is a benzodiazepine antagonist. It works by blocking receptors in the brain and central nervous system that benzodiazepines need to reach to be active, which helps reduce drowsiness and sedation caused by benzodiazepines.
When it should not be used:
If you have had an allergic reaction to Flumazenil or to benzodiazepines in the past
If you are allergic to any of the ingredients it contains (see
‘What the nonmedicinal ingredients are’)
If you are taking a benzodiazepine for control of a life- threatening condition (eg. Increased pressure in the head, seizures).
If you are experiencing side effects due to an overdose of a medicine used to treat depression
What the medicinal ingredient is:
Flumazenil
What the nonmedicinal ingredients are: methylparaben, propylparaben, sodium chloride, edetate disodium, acetic acid 0.1 mg, hydrochloric acid and/or sodium hydroxide to adjust pH and water for injection.
What dosage forms it comes in:
Flumazenil Injection 0.1 mg/mL is available in multidose vials of 5 mL and 10 mL, boxes of 5.
Latex-Free Stopper – Stopper contains no dry natural rubber.
WARNINGS AND PRECAUTIONS
Flumazenil Injection, USP may affect your ability to be alert.
Driving, operating machinery and other hazardous activities should therefore be avoided altogether for at least 24 hours.
You must not consume alcohol or other drugs that affect your central nervous system.
- Although Flumazenil Injection, USP is given to reverse drowsiness, you may experience a return of drowsiness for up to 24 hours after Flumazenil Injection, USP is given. If you notice a return of drowsiness or experience shortness of breath, contact your doctor as soon as possible.
BEFORE you use Flumazenil Injection, USP talk to your doctor or pharmacist if you:
- have liver problems
- have anxiety or panic disorders
- have heart problems or irregular heart beat
Are pregnant or planning to become pregnant, discuss with your doctor the benefits and risks of using Flumazenil Injection, USP during pregnancy.
Are breastfeeding as flumazenil may pass into breast milk.
Therefore, breast feeding should be interrupted for 24 hours when Flumazenil Injection, USP is used.
INTERACTIONS WITH THIS MEDICATION
Tell your doctor if you are taking any other medicines including any that you have bought from a pharmacy, supermarket or healthfood store without a prescription.
Some medicines may interfere with Flumazenil Injection, USP. These medicines include:
medicines within the benzodiazepine group (examples: clonazepam, chlordiazepoxide, diazepam, flurazepam or bromazepam)
These medicines are affected by Flumazenil Injection, USP. Your doctor or pharmacist can tell you what to do if you are taking any of these medicines.
If you have not told your doctor about any of the above, tell him/her before you start taking Flumazenil Injection, USP.
PROPER USE OF THIS MEDICATION
Usual dose:
Flumazenil Injection, USP should be administered intravenously by a physician with experienced in anaesthesiology at your doctor’s office, hospital or clinic. Your doctor will decide what dose you will receive which will depend on your particular condition.
Overdose:
SIDE EFFECTS AND WHAT TO DO ABOUT THEM
Like all medications Flumazenil Injection, USP can cause some side effects. For most patients these side effects are likely to be minor and temporary as your body adjusts to the medicine. However, some may be serious. Consult your doctor or pharmacist as soon as you can if you do not feel well while taking Flumazenil Injection, USP.
Seek urgent medical attention if you experience:
Allergic reactions (very rare)
If you have an allergic reaction, see a doctor straight away. The signs may include: sudden swelling of the throat, face, lips or mouth. This can make it difficult to breathe or swallow; sudden swelling of the hands, feet or ankles; skin rash or itching.
Convulsions (seizures)
These are more likely to happen in people who already have epilepsy or severe liver problems or people who have taken medicines called benzodiazepines for a long time.
The most common side effects are:
Nausea
Vomiting
Less common possible side effects are:
Feeling of anxiousness, fear or panic
Dizziness and sweating
Increase of blood pressure (flushing) and heart rate
Headaches, mood swings and chills
Rash, blurred vision, tremors, low blood pressure, urinary incontinence, and constipation
Panic attacks in patients that have a history of panic disorders
Withdrawal symptoms
If you have recently been taking a benzodiazepine (for example to help you sleep or to treat anxiety), you may get withdrawal symptoms after having Flumazenil Injection, USP. This may happen even if you stopped taking these medicines a few days or weeks before having Flumazenil Injection, USP. Withdrawal symptoms include disturbed sleep, depression, feeling nervous, feeling irritable, feeling dizzy, a rapid heartbeat, diarrhea and sweating.
This is not a complete list of side effects. For any unexpected effects while taking Flumazenil Injection, USP, contact your doctor, nurse or pharmacist.
HOW TO STORE IT
Keep Flumazenil Injection, USP in a cool dry place stored at room temperature (15-30°C). Protect from light. Discard unused portion 28 days after the initial puncture.
Flumazenil Injection, USP may be diluted with dextrose 5% solution or sodium chloride 0.9%. If flumazenil is drawn into a syringe or mixed with any of these solutions, it should be discarded after 24 hours.
Keep this medicine out of the reach of children.
REPORTING SUSPECTED SIDE EFFECTS
You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:
Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect. NOTE: Should you require information related to the management of the side effect, please contact your health care provider before notifying Canada Vigilance. The Canada Vigilance Program does not provide medical advice. |
MORE INFORMATION
This document can be found at: www.mylan.ca.
The full Product Monograph prepared for health professionals can be obtained by contacting the sponsor, Mylan Pharmaceuticals ULC at: 1-800-575-1379
Etobicoke, Ontario M8Z 2S6
Prepared on: August 15, 2014
Mylan Pharmaceuticals ULC
85 Advance Rd. Etobicoke, ON M8Z 2S6 1-800-575-1379 www.mylan.ca
In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.